[HTML][HTML] Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

HE White, M Salmon, F Albano, CSA Andersen… - Leukemia, 2022 - nature.com
Standardized monitoring of BCR:: ABL1 mRNA levels is essential for the management of
chronic myeloid leukemia (CML) patients. From 2016 to 2021 the European Treatment and …

[HTML][HTML] Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic …

DN Shelton, P Bhagavatula, N Sepulveda, L Beppu… - PLoS …, 2022 - journals.plos.org
Chronic myelogenous leukemia (CML) is a hematopoietic stem cell malignancy that
accounts for 15–20% of all cases of leukemia. CML is caused by a translocation between …

Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia

YJ Su, MC Kuo, TY Chen, MC Wang, Y Yang… - Cancer …, 2022 - Wiley Online Library
Several studies have compared the molecular responses between e14a2 and e13a2 BCR::
ABL1 transcripts in chronic myeloid leukemia (CML) patients treated with front‐line imatinib …

Identification and validation of suitable housekeeping genes for gene expression studies in BCR-ABL1 positive B-lineage acute lymphoblastic leukemia

DG Gupta, N Varma, A Kumar, S Naseem… - Molecular Biology …, 2022 - Springer
Background The stability of the housekeeping gene (HKG) expression is an absolute
prerequisite for accurate normalization of target gene expression in a quantitative real-time …

[引用][C] EBSCO Auth Banner

S Liu, H Larsson, P Lichtenstein, JF Ludvigsson… - Mobile Information Systems, 2022